We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 29.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2021 to Apr 2024
TIDMIDP
RNS Number : 0194E
InnovaDerma PLC
05 July 2021
InnovaDerma PLC
("InnovaDerma" or the "Company")
Change of Auditor
InnovaDerma (LSE: IDP), a UK developer of beauty, personal care, and life sciences products, is pleased to announce the appointment of Crowe U.K LLP ("Crowe") as the Company's auditor for the 2021 financial year. The appointment of Crowe as auditor for the following financial year will be subject to approval by shareholders at the next Annual General Meeting of the Company.
The appointment of Crowe follows the resignation of Elderton Audit UK ("Elderton"). The Board of InnovaDerma agreed with Elderton that the Company would be better served by auditors based in the United Kingdom where the Company's Board, management team and principal operations are located.
The Company will make a trading statement for the year ended 30 June 2021 on Thursday this week (8(th) July, 2021).
Further enquiries
Hot Features
Premium
InnovaDerma
Blake Hughes c/o TB Cardew
finncap Ltd
Geoff Nash/Kate Bannatyne +44 (0)207 220 0500
Alice Lane - Corporate Broking www.finncap.com
---------------------------
TB Cardew
Shan Shan Willenbrock/ + 44 (0)7775 848537
Olivia Rosser + 44 (0)20 7930 0777
innovaDerma @ tbcardew.com
---------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
APPDKBBQCBKKCOK
(END) Dow Jones Newswires
July 05, 2021 02:00 ET (06:00 GMT)
1 Year Innovaderma Chart |
1 Month Innovaderma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
